The p75NTR neutralization with a specific monoclonal antibody prevents CSCs survival signaling mediated by ERK in HNSC, and genetic loss of p75NTR in melanoma cells completely inhibits tumorigenicity in the xenograft model [84]. This evidence concerns the gene NGFR and melanoma.